Cargando…

The impact of a dose of the angiotensin receptor blocker valsartan on post‐myocardial infarction ventricular remodelling

AIMS: Although clinical guidelines advocate the use of the highest tolerated dose of angiotensin‐converting enzyme inhibitors or angiotensin receptor blockers after acute myocardial infarction (MI), the optimal dosing or the risk–benefit profile of different doses have not been fully identified. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Kyungil, Kim, Young‐Dae, Kim, Ki‐Sik, Lee, Su‐Hoon, Park, Tae‐Ho, Lee, Sang‐Gon, Kim, Byung‐Soo, Hur, Seung‐Ho, Yang, Tae‐Hyun, Oh, Joo‐Hyun, Hong, Taek‐Jong, Park, Jong‐Sun, Hwang, Jin‐Yong, Jeong, Byungcheon, Bae, Woo‐Hyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880661/ https://www.ncbi.nlm.nih.gov/pubmed/29341471 http://dx.doi.org/10.1002/ehf2.12249

Ejemplares similares

The impact of dose of the angiotensin-receptor blocker valsartan on the post-myocardial infarction ventricular remodeling: study protocol for a randomized controlled trial
por: Cho, Young-Rak, et al.
Publicado: (2011)

Preventive Effects of the Angiotensin-II Receptor Blocker on Atrial Remodeling in an Ischemic Heart Failure Model of Rats
por: Yoon, Namsik, et al.
Publicado: (2013)

Beneficial effects of an angiotensin-II receptor blocker on structural atrial reverse-remodeling in a rat model of ischemic heart failure
por: YOON, NAMSIK, et al.
Publicado: (2013)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

Design and Rationale for comParison Between ticagreLor and clopidogrEl on mIcrocirculation in Patients with Acute cOronary Syndrome Undergoing Percutaneous Coronary Intervention (PLEIO) Trial
por: Park, Kyungil, et al.
Publicado: (2018)

Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in Patient With Stable Chronic Heart Failure: Comparison With Enalapril
por: Lee, Young Soo, et al.
Publicado: (2011)

An Angiotensin Receptor Blocker Prevents Arrhythmogenic Left Atrial Remodeling in a Rat Post Myocardial Infarction Induced Heart Failure Model
por: Kim, Hyun-Su, et al.
Publicado: (2013)

Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2015)

Left ventricular geometric patterns in patients with type A aortic dissection
por: Kim, Soo-Jin, et al.
Publicado: (2019)

Prognostic effect of increased left ventricular wall thickness in severe aortic stenosis
por: Park, Kyungil, et al.
Publicado: (2021)

Fimasartan-induced liver injury in a patient with no adverse reactions on other types of angiotensin II receptor blockers: A case report
por: Park, Dae Hwa, et al.
Publicado: (2017)

Comparative Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers after Coronary Artery Bypass Grafting
por: Kim, Jeayoun, et al.
Publicado: (2020)

The Busan Regional CardioCerebroVascular Center Project’s Experience Over a Decade in the Treatment of ST-segment Elevation Myocardial Infarction
por: Lim, Kyunghee, et al.
Publicado: (2022)

Addition of Amlodipine or Valsartan for Improvement of Diastolic Dysfunction Associated with Hypertension
por: Oh, Jin Kyung, et al.
Publicado: (2020)

Comparison of prasugrel and clopidogrel reloading on high platelet reactivity in clopidogrel-loaded patients undergoing percutaneous coronary intervention (PRAISE-HPR): a study protocol for a prospective randomized controlled clinical trial
por: Lee, Dong-Hyun, et al.
Publicado: (2013)

Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
por: Kim, Hyue-Mee, et al.
Publicado: (2021)

Predicting the Size of Benign Thyroid Nodules and Analysis of Associated Factors That Affect Nodule Size
por: Seo, Seok Ho, et al.
Publicado: (2015)

Community-Based Pre-Hospital Electrocardiogram Transmission Program for Reducing Systemic Time Delay in Acute ST-Segment Elevation Myocardial Infarction
por: Park, Kyungil, et al.
Publicado: (2020)

Association between Cardiac Troponin Level and Coronary Flow Reserve in Patients without Coronary Artery Disease: Insight from a Thermodilution Technique Using an Intracoronary Pressure Wire
por: Park, Kyungil, et al.
Publicado: (2014)

Comparative effect of angiotensin converting enzyme inhibitor versus angiotensin II type I receptor blocker in acute myocardial infarction with non-obstructive coronary arteries; from the Korea Acute Myocardial Infarction Registry—National Institute of Health
por: Ahn, Joon Ho, et al.
Publicado: (2020)

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Observations of the Effects of Angiotensin II Receptor Blocker on Angiotensin II-Induced Morphological and Mechanical Changes in Renal Tubular Epithelial Cells Using Atomic Force Microscopy
por: Kim, Jin Sug, et al.
Publicado: (2018)

The angiotensin II type 1 receptor blocker valsartan in the battle against COVID‐19
por: de Ligt, Marlies, et al.
Publicado: (2021)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Reverse remodelling by sacubitril/valsartan predicts the prognosis in heart failure with reduced ejection fraction
por: Moon, Mi‐Gil, et al.
Publicado: (2021)

Seminal CD38 Enhances Human Sperm Capacitation through Its Interaction with CD31
por: Kim, Byung-Ju, et al.
Publicado: (2015)

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older heart failure patients with preserved ejection fraction: study protocol for a randomized controlled trial
por: Park, Kyungil, et al.
Publicado: (2016)

Comparative effects of nebivolol and carvedilol on left ventricular diastolic function in older patients with heart failure and preserved ejection fraction
por: Park, Kyungil, et al.
Publicado: (2023)

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
por: Shim, Kang Hee, et al.
Publicado: (2018)

Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis
por: Choi, Jin Sun, et al.
Publicado: (2023)

Alpha-Blocker Treatment Response in Men With Lower Urinary Tract Symptoms Based on Sympathetic Activity: Prospective, Multicenter, Open-Labeled, Observational Study
por: Park, Sung Gon, et al.
Publicado: (2015)

Positive Vascular Remodeling in Culprit Coronary Lesion is Associated With Plaque Composition: An Intravascular Ultrasound-Virtual Histology Study
por: Lee, Chung Seop, et al.
Publicado: (2012)

Clinical Effects of Calcium Channel Blocker and Angiotensin Converting Enzyme Inhibitor on Endothelial Function and Arterial Stiffness in Patients with Angina Pectoris
por: Kim, Kye Hun, et al.
Publicado: (2009)

Design and rationale for a comparison study of Olmesartan and Valsartan On myocardial metabolism In patients with Dilated cardiomyopathy (OVOID) trial: study protocol for a randomized controlled trial
por: Jo, Sua, et al.
Publicado: (2022)

Machine Learning-assisted Quantitative Mapping of Intracortical Axonal Plasticity Following a Focal Cortical Stroke in Rodents
por: Kim, Hyung Soon, et al.
Publicado: (2023)

Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lim, Sungmin, et al.
Publicado: (2019)

The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients
por: Oh, Ji‐Hye, et al.
Publicado: (2022)

Candesartan, an angiotensin-II receptor blocker, ameliorates insulin resistance and hepatosteatosis by reducing intracellular calcium overload and lipid accumulation
por: Lee, Jin Wook, et al.
Publicado: (2023)

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
por: Lee, Jae-Geun, et al.
Publicado: (2023)

Comparison of effects between calcium channel blocker and diuretics in combination with angiotensin II receptor blocker on 24-h central blood pressure and vascular hemodynamic parameters in hypertensive patients: study design for a multicenter, double-blinded, active-controlled, phase 4, randomized trial
por: Oh, Gyu Chul, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_eif92rkt8e02otldffcj4jnpas